Milestones in neuroimaging
Identifieur interne : 000579 ( Main/Corpus ); précédent : 000578; suivant : 000580Milestones in neuroimaging
Auteurs : A. Jon Stoessl ; David J. Brooks ; David EidelbergSource :
- Movement Disorders [ 0885-3185 ] ; 2011-05.
English descriptors
Abstract
In the last 25 years there have been enormous advances in brain imaging. In addition to utility in diagnosis, these have led to novel insights into the pathogenesis of basal ganglia disease and the role of dopamine and the basal ganglia in normal health. The authors review highlights of this work, with a focus on advances in Parkinson's disease, the dystonias, Huntington's disease, and the role of dopamine in cognition and reward signaling. Emerging areas for future development include studies of functional connectivity, the analysis of default mode networks, studies of novel neurochemical pathways, methods to study disease pathogenesis, and the application of imaging techniques to investigate animal models of disease. © 2011 Movement Disorder Society
Url:
DOI: 10.1002/mds.23679
Links to Exploration step
ISTEX:47D62F0F7B5893EACFD5ABA313611B87A63FFDD7Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Milestones in neuroimaging</title><author><name sortKey="Stoessl, A Jon" sort="Stoessl, A Jon" uniqKey="Stoessl A" first="A. Jon" last="Stoessl">A. Jon Stoessl</name><affiliation><mods:affiliation>Pacific Parkinson's Research Centre, University of British Columbia & Vancouver Coastal Health, Vancouver, British Columbia, Canada</mods:affiliation></affiliation></author><author><name sortKey="Brooks, David J" sort="Brooks, David J" uniqKey="Brooks D" first="David J." last="Brooks">David J. Brooks</name><affiliation><mods:affiliation>Centre for Neuroscience, Department of Medicine, Imperial College, Hammersmith Hospital, London, United Kingdom</mods:affiliation></affiliation></author><author><name sortKey="Eidelberg, David" sort="Eidelberg, David" uniqKey="Eidelberg D" first="David" last="Eidelberg">David Eidelberg</name><affiliation><mods:affiliation>Center for Neurosciences, Feinstein Institute for Medical Research, Manhasset, New York, USA</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:47D62F0F7B5893EACFD5ABA313611B87A63FFDD7</idno><date when="2011" year="2011">2011</date><idno type="doi">10.1002/mds.23679</idno><idno type="url">https://api.istex.fr/document/47D62F0F7B5893EACFD5ABA313611B87A63FFDD7/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">000579</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Milestones in neuroimaging</title><author><name sortKey="Stoessl, A Jon" sort="Stoessl, A Jon" uniqKey="Stoessl A" first="A. Jon" last="Stoessl">A. Jon Stoessl</name><affiliation><mods:affiliation>Pacific Parkinson's Research Centre, University of British Columbia & Vancouver Coastal Health, Vancouver, British Columbia, Canada</mods:affiliation></affiliation></author><author><name sortKey="Brooks, David J" sort="Brooks, David J" uniqKey="Brooks D" first="David J." last="Brooks">David J. Brooks</name><affiliation><mods:affiliation>Centre for Neuroscience, Department of Medicine, Imperial College, Hammersmith Hospital, London, United Kingdom</mods:affiliation></affiliation></author><author><name sortKey="Eidelberg, David" sort="Eidelberg, David" uniqKey="Eidelberg D" first="David" last="Eidelberg">David Eidelberg</name><affiliation><mods:affiliation>Center for Neurosciences, Feinstein Institute for Medical Research, Manhasset, New York, USA</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2011-05">2011-05</date><biblScope unit="volume">26</biblScope><biblScope unit="issue">6</biblScope><biblScope unit="page" from="868">868</biblScope><biblScope unit="page" to="978">978</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">47D62F0F7B5893EACFD5ABA313611B87A63FFDD7</idno><idno type="DOI">10.1002/mds.23679</idno><idno type="ArticleID">MDS23679</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Huntington disease</term><term>Parkinson's</term><term>dopamine</term><term>dystonia</term><term>positron emission tomography</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In the last 25 years there have been enormous advances in brain imaging. In addition to utility in diagnosis, these have led to novel insights into the pathogenesis of basal ganglia disease and the role of dopamine and the basal ganglia in normal health. The authors review highlights of this work, with a focus on advances in Parkinson's disease, the dystonias, Huntington's disease, and the role of dopamine in cognition and reward signaling. Emerging areas for future development include studies of functional connectivity, the analysis of default mode networks, studies of novel neurochemical pathways, methods to study disease pathogenesis, and the application of imaging techniques to investigate animal models of disease. © 2011 Movement Disorder Society</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>A. Jon Stoessl CM, MD, FRCPC</name><affiliations><json:string>Pacific Parkinson's Research Centre, University of British Columbia & Vancouver Coastal Health, Vancouver, British Columbia, Canada</json:string></affiliations></json:item><json:item><name>David J. Brooks MD, DSc, FRCP, FMedSci</name><affiliations><json:string>Centre for Neuroscience, Department of Medicine, Imperial College, Hammersmith Hospital, London, United Kingdom</json:string></affiliations></json:item><json:item><name>David Eidelberg MD</name><affiliations><json:string>Center for Neurosciences, Feinstein Institute for Medical Research, Manhasset, New York, USA</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Parkinson's</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>dystonia</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Huntington disease</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>dopamine</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>positron emission tomography</value></json:item></subject><articleId><json:string>MDS23679</json:string></articleId><language><json:string>eng</json:string></language><abstract>In the last 25 years there have been enormous advances in brain imaging. In addition to utility in diagnosis, these have led to novel insights into the pathogenesis of basal ganglia disease and the role of dopamine and the basal ganglia in normal health. The authors review highlights of this work, with a focus on advances in Parkinson's disease, the dystonias, Huntington's disease, and the role of dopamine in cognition and reward signaling. Emerging areas for future development include studies of functional connectivity, the analysis of default mode networks, studies of novel neurochemical pathways, methods to study disease pathogenesis, and the application of imaging techniques to investigate animal models of disease. © 2011 Movement Disorder Society</abstract><qualityIndicators><score>6.392</score><pdfVersion>1.3</pdfVersion><pdfPageSize>612 x 810 pts</pdfPageSize><refBibsNative>true</refBibsNative><keywordCount>5</keywordCount><abstractCharCount>761</abstractCharCount><pdfWordCount>8435</pdfWordCount><pdfCharCount>57735</pdfCharCount><pdfPageCount>11</pdfPageCount><abstractWordCount>116</abstractWordCount></qualityIndicators><title>Milestones in neuroimaging</title><genre><json:string>review-article</json:string></genre><host><volume>26</volume><publisherId><json:string>MDS</json:string></publisherId><pages><total>111</total><last>978</last><first>868</first></pages><issn><json:string>0885-3185</json:string></issn><issue>6</issue><subject><json:item><value>Review</value></json:item></subject><genre><json:string>Journal</json:string></genre><language><json:string>unknown</json:string></language><eissn><json:string>1531-8257</json:string></eissn><title>Movement Disorders</title><doi><json:string>10.1002/(ISSN)1531-8257</json:string></doi></host><publicationDate>2011</publicationDate><copyrightDate>2011</copyrightDate><doi><json:string>10.1002/mds.23679</json:string></doi><id>47D62F0F7B5893EACFD5ABA313611B87A63FFDD7</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/47D62F0F7B5893EACFD5ABA313611B87A63FFDD7/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/47D62F0F7B5893EACFD5ABA313611B87A63FFDD7/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/47D62F0F7B5893EACFD5ABA313611B87A63FFDD7/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Milestones in neuroimaging</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><availability><p>WILEY</p></availability><date>2011</date></publicationStmt><notesStmt><note type="content">*Relevant conflicts of interest/financial disclosures: The authors' work is supported by the Canada Research Chairs program, the Canadian Institutes of Health Research, the Michael Smith Foundation for Health Research and the Pacific Alzheimer Research Foundation (to A.J.S.), the UK Medical Research Council, UK Parkinson's Disease Society, Michael J. Fox Foundation, European Union Framework Programme (to D.J.B.), National Institutes of Health/NINDS, Parkinson's Disease Foundation, American Parkinson Disease Foundation, Dystonia Medical Research Foundation, Bachmann‐Strauss Dystonia & Parkinson Foundation, and CHDI/High Q Foundation (to D.E.).</note><note type="content">*Full financial disclosures and author roles may be found in the online version of this article.</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Milestones in neuroimaging</title><author><persName><forename type="first">A. Jon</forename><surname>Stoessl</surname></persName><roleName type="degree">CM, MD, FRCPC</roleName><note type="correspondence"><p>Correspondence: 2221 Wesbrook Mall, Vancouver, BC, Canada V6T 2B5</p></note><affiliation>Pacific Parkinson's Research Centre, University of British Columbia & Vancouver Coastal Health, Vancouver, British Columbia, Canada</affiliation></author><author><persName><forename type="first">David J.</forename><surname>Brooks</surname></persName><roleName type="degree">MD, DSc, FRCP, FMedSci</roleName><affiliation>Centre for Neuroscience, Department of Medicine, Imperial College, Hammersmith Hospital, London, United Kingdom</affiliation></author><author><persName><forename type="first">David</forename><surname>Eidelberg</surname></persName><roleName type="degree">MD</roleName><affiliation>Center for Neurosciences, Feinstein Institute for Medical Research, Manhasset, New York, USA</affiliation></author></analytic><monogr><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="pISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><idno type="DOI">10.1002/(ISSN)1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2011-05"></date><biblScope unit="volume">26</biblScope><biblScope unit="issue">6</biblScope><biblScope unit="page" from="868">868</biblScope><biblScope unit="page" to="978">978</biblScope></imprint></monogr><idno type="istex">47D62F0F7B5893EACFD5ABA313611B87A63FFDD7</idno><idno type="DOI">10.1002/mds.23679</idno><idno type="ArticleID">MDS23679</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2011</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>In the last 25 years there have been enormous advances in brain imaging. In addition to utility in diagnosis, these have led to novel insights into the pathogenesis of basal ganglia disease and the role of dopamine and the basal ganglia in normal health. The authors review highlights of this work, with a focus on advances in Parkinson's disease, the dystonias, Huntington's disease, and the role of dopamine in cognition and reward signaling. Emerging areas for future development include studies of functional connectivity, the analysis of default mode networks, studies of novel neurochemical pathways, methods to study disease pathogenesis, and the application of imaging techniques to investigate animal models of disease. © 2011 Movement Disorder Society</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head><item><term>Parkinson's</term></item><item><term>dystonia</term></item><item><term>Huntington disease</term></item><item><term>dopamine</term></item><item><term>positron emission tomography</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>article category</head><item><term>Review</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2010-09-23">Received</change><change when="2011-01-23">Registration</change><change when="2011-05">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/47D62F0F7B5893EACFD5ABA313611B87A63FFDD7/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName><publisherLoc>Hoboken</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1531-8257</doi><issn type="print">0885-3185</issn><issn type="electronic">1531-8257</issn><idGroup><id type="product" value="MDS"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title><title type="short">Mov. Disord.</title></titleGroup></publicationMeta><publicationMeta level="part" position="60"><doi origin="wiley" registered="yes">10.1002/mds.v26.6</doi><titleGroup><title type="specialIssueTitle">25th Anniversary</title></titleGroup><numberingGroup><numbering type="journalVolume" number="26">26</numbering><numbering type="journalIssue">6</numbering></numberingGroup><coverDate startDate="2011-05">May 2011</coverDate></publicationMeta><publicationMeta level="unit" type="reviewArticle" position="60" status="forIssue"><doi origin="wiley" registered="yes">10.1002/mds.23679</doi><idGroup><id type="unit" value="MDS23679"></id></idGroup><countGroup><count type="pageTotal" number="111"></count></countGroup><titleGroup><title type="articleCategory">Review</title><title type="tocHeading1">Reviews</title></titleGroup><copyright ownership="thirdParty">Copyright © 2011 Movement Disorder Society</copyright><eventGroup><event type="manuscriptReceived" date="2010-09-23"></event><event type="manuscriptRevised" date="2010-12-31"></event><event type="manuscriptAccepted" date="2011-01-23"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:3.0.1 mode:FullText" date="2012-01-27"></event><event type="publishedOnlineFinalForm" date="2011-05-27"></event><event type="firstOnline" date="2011-05-27"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event></eventGroup><numberingGroup><numbering type="pageFirst">868</numbering><numbering type="pageLast">978</numbering></numberingGroup><correspondenceTo>2221 Wesbrook Mall, Vancouver, BC, Canada V6T 2B5</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:MDS.MDS23679.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="5"></count><count type="tableTotal" number="0"></count><count type="referenceTotal" number="197"></count><count type="wordTotal" number="10663"></count></countGroup><titleGroup><title type="main" xml:lang="en">Milestones in neuroimaging<link href="#fn1"></link><link href="#fn2"></link></title><title type="short" xml:lang="en">Milestones in Neuroimaging</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><givenNames>A. Jon</givenNames><familyName>Stoessl</familyName><degrees>CM, MD, FRCPC</degrees></personName><contactDetails><email>jstoessl@interchange.ubc.ca</email></contactDetails></creator><creator xml:id="au2" creatorRole="author" affiliationRef="#af2"><personName><givenNames>David J.</givenNames><familyName>Brooks</familyName><degrees>MD, DSc, FRCP, FMedSci</degrees></personName></creator><creator xml:id="au3" creatorRole="author" affiliationRef="#af3"><personName><givenNames>David</givenNames><familyName>Eidelberg</familyName><degrees>MD</degrees></personName></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="CA" type="organization"><unparsedAffiliation>Pacific Parkinson's Research Centre, University of British Columbia & Vancouver Coastal Health, Vancouver, British Columbia, Canada</unparsedAffiliation></affiliation><affiliation xml:id="af2" countryCode="GB" type="organization"><unparsedAffiliation>Centre for Neuroscience, Department of Medicine, Imperial College, Hammersmith Hospital, London, United Kingdom</unparsedAffiliation></affiliation><affiliation xml:id="af3" countryCode="US" type="organization"><unparsedAffiliation>Center for Neurosciences, Feinstein Institute for Medical Research, Manhasset, New York, USA</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">Parkinson's</keyword><keyword xml:id="kwd2">dystonia</keyword><keyword xml:id="kwd3">Huntington disease</keyword><keyword xml:id="kwd4">dopamine</keyword><keyword xml:id="kwd5">positron emission tomography</keyword></keywordGroup><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>In the last 25 years there have been enormous advances in brain imaging. In addition to utility in diagnosis, these have led to novel insights into the pathogenesis of basal ganglia disease and the role of dopamine and the basal ganglia in normal health. The authors review highlights of this work, with a focus on advances in Parkinson's disease, the dystonias, Huntington's disease, and the role of dopamine in cognition and reward signaling. Emerging areas for future development include studies of functional connectivity, the analysis of default mode networks, studies of novel neurochemical pathways, methods to study disease pathogenesis, and the application of imaging techniques to investigate animal models of disease. © 2011 Movement Disorder Society</p></abstract></abstractGroup></contentMeta><noteGroup><note xml:id="fn1"><p><b>Relevant conflicts of interest/financial disclosures:</b> The authors' work is supported by the Canada Research Chairs program, the Canadian Institutes of Health Research, the Michael Smith Foundation for Health Research and the Pacific Alzheimer Research Foundation (to A.J.S.), the UK Medical Research Council, UK Parkinson's Disease Society, Michael J. Fox Foundation, European Union Framework Programme (to D.J.B.), National Institutes of Health/NINDS, Parkinson's Disease Foundation, American Parkinson Disease Foundation, Dystonia Medical Research Foundation, Bachmann‐Strauss Dystonia & Parkinson Foundation, and CHDI/High Q Foundation (to D.E.).</p></note><note xml:id="fn2"><p>Full financial disclosures and author roles may be found in the online version of this article.</p></note></noteGroup></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Milestones in neuroimaging</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Milestones in Neuroimaging</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Milestones in neuroimaging</title></titleInfo><name type="personal"><namePart type="given">A. Jon</namePart><namePart type="family">Stoessl</namePart><namePart type="termsOfAddress">CM, MD, FRCPC</namePart><affiliation>Pacific Parkinson's Research Centre, University of British Columbia & Vancouver Coastal Health, Vancouver, British Columbia, Canada</affiliation><description>Correspondence: 2221 Wesbrook Mall, Vancouver, BC, Canada V6T 2B5</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">David J.</namePart><namePart type="family">Brooks</namePart><namePart type="termsOfAddress">MD, DSc, FRCP, FMedSci</namePart><affiliation>Centre for Neuroscience, Department of Medicine, Imperial College, Hammersmith Hospital, London, United Kingdom</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">David</namePart><namePart type="family">Eidelberg</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Center for Neurosciences, Feinstein Institute for Medical Research, Manhasset, New York, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="review-article" displayLabel="reviewArticle"></genre><originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><place><placeTerm type="text">Hoboken</placeTerm></place><dateIssued encoding="w3cdtf">2011-05</dateIssued><dateCaptured encoding="w3cdtf">2010-09-23</dateCaptured><dateValid encoding="w3cdtf">2011-01-23</dateValid><copyrightDate encoding="w3cdtf">2011</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="figures">5</extent><extent unit="references">197</extent><extent unit="words">10663</extent></physicalDescription><abstract lang="en">In the last 25 years there have been enormous advances in brain imaging. In addition to utility in diagnosis, these have led to novel insights into the pathogenesis of basal ganglia disease and the role of dopamine and the basal ganglia in normal health. The authors review highlights of this work, with a focus on advances in Parkinson's disease, the dystonias, Huntington's disease, and the role of dopamine in cognition and reward signaling. Emerging areas for future development include studies of functional connectivity, the analysis of default mode networks, studies of novel neurochemical pathways, methods to study disease pathogenesis, and the application of imaging techniques to investigate animal models of disease. © 2011 Movement Disorder Society</abstract><note type="content">*Relevant conflicts of interest/financial disclosures: The authors' work is supported by the Canada Research Chairs program, the Canadian Institutes of Health Research, the Michael Smith Foundation for Health Research and the Pacific Alzheimer Research Foundation (to A.J.S.), the UK Medical Research Council, UK Parkinson's Disease Society, Michael J. Fox Foundation, European Union Framework Programme (to D.J.B.), National Institutes of Health/NINDS, Parkinson's Disease Foundation, American Parkinson Disease Foundation, Dystonia Medical Research Foundation, Bachmann‐Strauss Dystonia & Parkinson Foundation, and CHDI/High Q Foundation (to D.E.).</note><note type="content">*Full financial disclosures and author roles may be found in the online version of this article.</note><subject lang="en"><genre>Keywords</genre><topic>Parkinson's</topic><topic>dystonia</topic><topic>Huntington disease</topic><topic>dopamine</topic><topic>positron emission tomography</topic></subject><relatedItem type="host"><titleInfo><title>Movement Disorders</title></titleInfo><titleInfo type="abbreviated"><title>Mov. Disord.</title></titleInfo><genre type="Journal">journal</genre><subject><genre>article category</genre><topic>Review</topic></subject><identifier type="ISSN">0885-3185</identifier><identifier type="eISSN">1531-8257</identifier><identifier type="DOI">10.1002/(ISSN)1531-8257</identifier><identifier type="PublisherID">MDS</identifier><part><date>2011</date><detail type="title"><title>25th Anniversary</title></detail><detail type="volume"><caption>vol.</caption><number>26</number></detail><detail type="issue"><caption>no.</caption><number>6</number></detail><extent unit="pages"><start>868</start><end>978</end><total>111</total></extent></part></relatedItem><identifier type="istex">47D62F0F7B5893EACFD5ABA313611B87A63FFDD7</identifier><identifier type="DOI">10.1002/mds.23679</identifier><identifier type="ArticleID">MDS23679</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 2011 Movement Disorder Society</accessCondition><recordInfo><recordContentSource>WILEY</recordContentSource><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000579 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000579 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= ISTEX:47D62F0F7B5893EACFD5ABA313611B87A63FFDD7
|texte= Milestones in neuroimaging
}}
| This area was generated with Dilib version V0.6.23. |  |